172 related articles for article (PubMed ID: 36208139)
1. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ
Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study.
Bai W; Zhang J; Wang Y; Zhou M; Liu L; Wang G; Zhao K; Gao X; Li S
Expert Rev Anticancer Ther; 2022 Feb; 22(2):215-228. PubMed ID: 34596477
[TBL] [Abstract][Full Text] [Related]
4. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
[TBL] [Abstract][Full Text] [Related]
5. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
Zhang Y; Sun Y; Chen H
Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
[TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
Li F; Zhao Y; Yuan L; Wang S; Mao Y
J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
[TBL] [Abstract][Full Text] [Related]
7. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
Kagimoto A; Tsutani Y; Kushitani K; Kai Y; Kambara T; Miyata Y; Takeshima Y; Okada M
Ann Thorac Surg; 2021 Sep; 112(3):935-943. PubMed ID: 33144104
[TBL] [Abstract][Full Text] [Related]
8. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
9. Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection.
Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1043-1051. PubMed ID: 28204972
[TBL] [Abstract][Full Text] [Related]
10. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
11. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
Liu Y; Huang C; Liu H; Chen Y; Li S
World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm.
Song W; Hou Y; Zhang J; Zhou Q
Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370
[TBL] [Abstract][Full Text] [Related]
13. Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis.
Chen C; Ni Q; Shi Y; Fu S; Pan X; Wang Y; Yang J; Wang R
Transl Cancer Res; 2019 Apr; 8(2):574-582. PubMed ID: 35116790
[TBL] [Abstract][Full Text] [Related]
14. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
Chiang XH; Hsu HH; Hsieh MS; Chang CH; Tsai TM; Liao HC; Tsou KC; Lin MW; Chen JS
Ann Surg Oncol; 2020 Mar; 27(3):703-715. PubMed ID: 31646453
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
[TBL] [Abstract][Full Text] [Related]
17. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
18. Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.
Kameda K; Eguchi T; Lu S; Qu Y; Tan KS; Kadota K; Adusumilli PS; Travis WD
J Thorac Oncol; 2018 Dec; 13(12):1919-1929. PubMed ID: 30195703
[TBL] [Abstract][Full Text] [Related]
19. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.
Qiu C; Wang G; Xu J; Cui L; Dong W; Ni Y; Qu X; Du J
Int J Surg; 2017 Jan; 37():1-7. PubMed ID: 27890654
[TBL] [Abstract][Full Text] [Related]
20. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
